Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Management of polycythemia vera to reduce thrombotic events and mortality with phlebotomy and cytoreductive therapy in veterans affairs healthcare system.
Journal: Cancer treatment and research communications
Published: June 10, 2026
Ropeginterferon alfa-2b-njft treatment in essential thrombocythemia across different driver mutations: results from a North American, single-arm, multicentre study (EXCEED-ET).
Journal: Lancet regional health. Americas
Published: March 25, 2026
Avapritinib achieves long-term disease control with favorable safety in patients with indolent systemic mastocytosis over 3 years.
Journal: The Journal of allergy and clinical immunology
Published: December 16, 2025
Correction to: Mastocytosis in the Skin: Approach to Diagnosis, Evaluation, and Management in Adult and Pediatric Patients.
Journal: American journal of clinical dermatology
Published: July 23, 2025
Metformin alleviates side effects and supports the resumption of interferon therapy in polycythemia vera and essential thrombocythemia.
Journal: Haematologica
Published: June 16, 2025
Ropeginterferon alfa-2b in hydroxyurea-intolerant or hydroxyurea-refractory essential thrombocythaemia (SURPASS ET): a multicentre, open-label, randomised, active-controlled, phase 3 study.
Journal: The Lancet. Haematology
Published: June 11, 2025
Highlights from MPN Asia 2025: Advances in Molecular Pathogenesis and Therapeutic Strategies in Myeloproliferative Neoplasms.
Journal: Current hematologic malignancy reports
Published: June 10, 2025
Mastocytosis in the Skin: Approach to Diagnosis, Evaluation, and Management in Adult and Pediatric Patients.
Journal: American journal of clinical dermatology
Published: April 07, 2025
Last Updated: 09/26/2026